Abbott secures Bigfoot Biomedical to boost diabetes care tech
Abbott has wrapped up the previously announced acquisition of Bigfoot Biomedical. The latter which is a Silicon Valley-based front-runner is celebrated for its revolutionary smart insulin management systems, notably enhancing diabetes care for patients worldwide. This acquisition propels Abbott’s standing in the diabetes domain, complementing its dominant FreeStyle Libre suite – a state-of-the-art continuous glucose […]